Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

PACB stock hub

Pacific Biosciences of California, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PACBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

437.9M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

PACB

In the news

Latest news · PACB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-273.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-13.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PACB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

220

Groups with data

Currency

USD

Showing 220 of 220 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001299130
Company name	Pacific Biosciences of California, Inc.
Country	United States
Country code	US
Cusip	69404D108
Employees	485
Employees Change	-90%
Employees Change Percent	-15.65
Enterprise value	$868.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	2010-10-27
Isin	US69404D1081
Last refreshed	2026-05-10
Market cap	$437.9M
Market cap category	Small-Cap
Price	$1.41
Price currency	USD
Rev Per Employee	329,958.76x
Sector	Healthcare
Sic	3826
Symbol	PACB
Website	https://www.pacb.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-29.36%
EV Sales Forward	4.89x
EV/Sales	5.43x
FCF yield	-26.54%
P/B ratio	182.26x
P/S ratio	2.74x
PS Forward	2.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-98.28%
EBITDA Margin	-89.45%
Gross margin	38.33%
Gross Profit	$61.3M
Gross Profit Growth	45.72%
Gross Profit Growth Q	92.05%
Gross Profit Growth3 Y	7.71%
Gross Profit Growth5 Y	10.02%
Net Income	$-128.6M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-79.84%
Profit Margin	-80.34%
Profit Per Employee	$-265,105
ROA	-11.96
Roa5y	-15.23
ROCE	-21.94
ROE	-273.6
Roe5y	-78.38
ROIC	-13.08

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-16.64%
Cagr15y	-12.52%
Cagr1y	24.8%
Cagr3y	-51.27%
Cagr5y	-43.69%
EPS Growth Quarters	4
EPS Growth Years	0
Revenue Growth	5.04x
Revenue Growth Q	0.07x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	6.09x
Revenue Growth5 Y	11.64x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.19
Assets	$782.4M
Cash	$276M
Current Assets	$369.5M
Current Liabilities	$65.4M
Debt	$706.4M
Debt Equity	$299
Equity	$2.4M
Interest Coverage	-22.61
Liabilities	$780M
Long Term Assets	$412.8M
Long Term Liabilities	$714.6M
Net Cash	$-430.4M
Net Cash By Market Cap	$-98.28
Net Debt Equity	$182
Tangible Book Value	$-329.5M
Tangible Book Value Per Share	$-1.06
WACC	7.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.65
Inventory Turnover	1.88
Net Working Capital	$31.5M
Quick ratio	4.67
Working Capital	$304.2M
Working Capital Turnover	$0.47

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-7.43%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-83.79%
1Y total return	24.78%
200-day SMA	1.68
3Y total return	-88.43%
50-day SMA	1.48
50-day SMA vs 200-day SMA	50under200
5Y total return	-94.34%
All Time High	53.69
All Time High Change	-97.37%
All Time High Date	2021-02-11
All Time Low	0.85
All Time Low Change	65.67%
All Time Low Date	2025-05-28
ATR	0.13
Beta	2.4
Beta1y	2.2
Beta2y	1.06
Ch YTD	-24.6
High	1.52
High52	2.73
High52 Date	2026-01-23
High52ch	-48.35%
Low	1.35
Low52	0.85
Low52 Date	2025-05-28
Low52ch	65.67%
Ma50ch	-4.54%
Premarket Change Percent	-7.88
Premarket Price	$1.52
Premarket Volume	282,668
Price vs 200-day SMA	-16.27%
RSI	42.15
RSI Monthly	40.45
RSI Weekly	44.71
Sharpe ratio	0.64x
Sortino ratio	1.12
Total Return	-7.43%
Tr YTD	-24.6
Tr15y	-86.56%
Tr1m	-2.08%
Tr1w	-11.88%
Tr3m	-22.53%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	1
Analyst Price Target Top	$2
Analyst Ratings	Hold
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.14
Earnings Revenue Estimate	40,182,240x
Earnings Revenue Estimate Growth	8.15x
Operating Income	$-157.3M
Operating margin	-98.28
Price target	$1.67
Price Target Change	$18.44
Price Target Change Top	$41.84

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	302,237,398%
Float Percent	97.31%
Shares Insiders	1.53%
Shares Institutions	60.42%
Shares Out	310,601,688
Shares Qo Q	1.3%
Shares Yo Y	7.43%
Short Float	15.34%
Short Ratio	8.44
Short Shares	14.93

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-153.1M
Average Volume	6,359,213x
Bv Per Share	0.01
CAPEX	$-4.4M
Ch10y	-83.79
Ch15y	-86.56
Ch1m	-2.08
Ch1w	-11.88
Ch1y	24.78
Ch3m	-22.53
Ch3y	-88.43
Ch5y	-94.34
Ch6m	-19.89
Change	-14.55%
Change From Open	-7.24
Close	1.65
Days Gap	-7.88
Depreciation Amortization	14,134,000
Dollar Volume	13,917,082.1
Earnings Date	2026-05-07
Earnings Time	amc
EBIT	$-157.3M
EBITDA	$-143.1M
EPS	$-0.43
F Score	4
FCF	$-116.2M
FCF EV Yield	-13.38x
FCF Per Share	$-0.37
Financing CF	2,906,000
Fiscal Year End	December
Founded	2,000
Goodwill	317,761,000
Income Tax	$804,000
Investing CF	106,073,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-25
Ma150	1.81
Ma150ch	-21.97%
Ma20	1.6
Ma20ch	-11.82%
Net CF	-2,865,000
Next Earnings Date	2026-08-06
Open	1.52
Optionable	Yes
Position In Range	35.29
Post Close	1.41
Postmarket Change Percent	1.42
Postmarket Price	$1.43
Ppne	65,222,000
Pre Close	1.65
Price Date	2026-05-08
Relative Volume	1.55x
Revenue	160,030,000x
SBC By Revenue	23.07x
Share Based Comp	36,926,000
Tax By Revenue	0.5x
Tr6m	-19.89%
Us State	California
Volume	9,870,271
Z Score	-4.47

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does PACB pay a dividend?

Capital-return profile for this ticker.

Performance

PACB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns PACB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+60.4%

Float: +97.3% of shares outstanding

Insider ownership

+1.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

PACB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.1

Neutral momentum band

Price vs 200-day MA

-16.3%

50/200-day relationship not available

Beta (5Y)

2.40

More volatile than the market

Sharpe ratio

0.64

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PACB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PACB stock rating?

Pacific Biosciences of California, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PACB analysis?

The full report lives at /stocks/PACB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PACB?

The latest report frames PACB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PACB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.